CN108969666A - It is a kind of to treat rheumatism bone disease, plaster of traumatic injury and preparation method thereof - Google Patents
It is a kind of to treat rheumatism bone disease, plaster of traumatic injury and preparation method thereof Download PDFInfo
- Publication number
- CN108969666A CN108969666A CN201811151016.7A CN201811151016A CN108969666A CN 108969666 A CN108969666 A CN 108969666A CN 201811151016 A CN201811151016 A CN 201811151016A CN 108969666 A CN108969666 A CN 108969666A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- rhizoma
- plaster
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Abstract
The present invention relates to technical field of traditional Chinese medicines, rheumatism bone disease is treated more particularly to a kind of, plaster of traumatic injury and preparation method thereof, the plaster is made of raw material from the following weight: 10~20 parts by weight of rhizoma typhonii, 10~20 parts by weight of lopseed, 10~20 parts by weight of prepared fleece flower root, 10~20 parts by weight of pangolin, 10~20 parts by weight of safflower, 15~30 parts by weight of ginseng, 20~40 parts by weight of the rhizome of davallia, 20~40 parts by weight of glutinous rehmannia, 20~40 parts by weight of olibanum, 15~50 parts by weight of radix cyathulae, 15~50 parts by weight of Rhizoma Et Radix Notopterygii, 15~50 parts by weight of Rhizoma Gastrodiae, 15~50 parts by weight of Rhizoma Chuanxiong, 15~50 parts by weight of zaocys dhumnade, 15~50 parts by weight of ramulus mori, 15~50 parts by weight of rhizoma corydalis, 15~50 parts by weight of Radix Angelicae Sinensis, peppermint 15~ 50 parts by weight, 15~50 parts by weight of borneol, 50~70 parts by weight of Radix Notoginseng, 100~300 parts by weight of ethylene glycol, 3000~6000 parts by weight of sesame oil, 1500~3000 parts by weight of wide pellet.Plaster of the invention has activating microcirculation and removing stasis medicinal, wards off the cold and removes the effect of pain, has good curative effect to rheumatism bone disease, traumatic injury, and quick, short treating period, cure rate are high.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines more particularly to a kind of treat rheumatism bone disease, the plaster of traumatic injury and its system
Preparation Method.
Background technique
Rheumatism, rheumatoid are a kind of common inflammation, and rheumatic disease is to refer to influence bone, joint and its surrounding soft tissue
Such as tendon, synovial membrane, fascia one group of disease have rheumatic bone using pain such as joint, muscle, soft tissue, nerves as cardinal symptom
The diseases such as disease, rheumatoid osteopathia, protrusion of lumber intervertebral disc, osteoproliferation, with arthralgia, aching and tired, numb, limitation of activity, stiff change
Shape is main clinical manifestation, serious to be unable to leave the bed, in great pain, be can't take care of oneself.Motherland's medicine thinks that this disease belongs to " numbness
The range of disease ".The factor for inducing this disease is the muscles and bones dystrophy because of human liver, spleen, kidney asthenia of essence and blood, wind, cold, wet in nature,
The evil intrusion human body of heat hinders qi and blood numbness, causes QI-blood circulation unsmooth, cause blockage of main and collateral channels or phlegm-turbidity and blood stasis blood into joint.Or
Work and rest wound causes hemostasis to stagnate, passages through which vital energy circulates is obstructed, causes arthralgia, extremity numbness, anchylosis, bends the symptoms such as body is unfavorable.
Treatment rheumatism bone disease, rheumatoid mainly use the Western medicine of plaster and anti-inflammatory class at present, and although Western medicine has compares reason
The anti-inflammatory analgesic effect thought, but can not improve basic lesion, and symptom again repeatedly, even more aggravates, and use for a long time after drug withdrawal
Medicine can produce adverse reaction and toxic side effect.There is moon shaped face, buffalo hump, acne, crinosity, induction as class adrenal cortex is hyperfunction
Ulcer is aggravated, infection, mental symptom, inhibits growth and development, increase blood lipid, blood glucose, blood pressure, especially induced osteoporosis, stock
The adverse reactions such as head necrosis, hypoadrenocorticism and atrophy are far longer than drug therapy effect, cause essence to patient
Mind, the human body, economically bigger pain.The drug effect of the drug of the disease of existing treatment rheumatism bone disease class is unobvious, and the period compares
It is long, and be easy repeatedly, long-term administration can bring the degeneration of physical function.
Summary of the invention
In view of the deficiencies of the prior art, the present invention provides a kind of plaster for treating rheumatism bone disease, traumatic injury, it, which has, lives
Blood stagnation resolvation wards off the cold and removes the effect of pain, has good curative effect to rheumatism bone disease, and quick, short treating period, cure rate are high.
In order to solve the above technical problems, the present invention provides a kind of plaster for treating rheumatism bone disease, traumatic injury, the plaster
It is made of raw material from the following weight: 10~20 parts by weight of rhizoma typhonii, 10~20 parts by weight of lopseed, 10~20 weight of prepared fleece flower root
Amount part, 10~20 parts by weight of pangolin, 10~20 parts by weight of safflower, 15~30 parts by weight of ginseng, 20~40 parts by weight of the rhizome of davallia,
20~40 parts by weight of glutinous rehmannia, 20~40 parts by weight of olibanum, 15~50 parts by weight of radix cyathulae, 15~50 parts by weight of Rhizoma Et Radix Notopterygii, Rhizoma Gastrodiae 15
~50 parts by weight, 15~50 parts by weight of Rhizoma Chuanxiong, 15~50 parts by weight of zaocys dhumnade, 15~50 parts by weight of ramulus mori, rhizoma corydalis 15~50
Parts by weight, 15~50 parts by weight of Radix Angelicae Sinensis, 15~50 parts by weight of peppermint, 15~50 parts by weight of borneol, 50~70 parts by weight of Radix Notoginseng, second
100~300 parts by weight of glycol, 3000~6000 parts by weight of sesame oil, 1500~3000 parts by weight of wide pellet.
Under optimum condition, the plaster is made of raw material from the following weight: 15 parts by weight of rhizoma typhonii, 15 weight of lopseed
Part, 12 parts by weight of prepared fleece flower root, 15 parts by weight of pangolin, 18 parts by weight of safflower, 25 parts by weight of ginseng, 30 parts by weight of the rhizome of davallia,
30 parts by weight of glutinous rehmannia, 25 parts by weight of olibanum, 25 parts by weight of radix cyathulae, 25 parts by weight of Rhizoma Et Radix Notopterygii, 25 parts by weight of Rhizoma Gastrodiae, 30 weight of Rhizoma Chuanxiong
Part, 30 parts by weight of zaocys dhumnade, 25 parts by weight of ramulus mori, 25 parts by weight of rhizoma corydalis, 25 parts by weight of Radix Angelicae Sinensis, 40 parts by weight of peppermint, borneol
40 parts by weight, 60 parts by weight of Radix Notoginseng, 200 parts by weight of ethylene glycol, 5000 parts by weight of sesame oil, 2000 parts by weight of wide pellet.
Under optimum condition, the plaster is made of raw material from the following weight: 12 parts by weight of rhizoma typhonii, 12 weight of lopseed
Part, 18 parts by weight of prepared fleece flower root, 15 parts by weight of pangolin, 15 parts by weight of safflower, 20 parts by weight of ginseng, 25 parts by weight of the rhizome of davallia,
30 parts by weight of glutinous rehmannia, 30 parts by weight of olibanum, 36 parts by weight of radix cyathulae, 36 parts by weight of Rhizoma Et Radix Notopterygii, 36 parts by weight of Rhizoma Gastrodiae, 25 weight of Rhizoma Chuanxiong
Part, 25 parts by weight of zaocys dhumnade, 30 parts by weight of ramulus mori, 25 parts by weight of rhizoma corydalis, 36 parts by weight of Radix Angelicae Sinensis, 45 parts by weight of peppermint, borneol
36 parts by weight, 60 parts by weight of Radix Notoginseng, 150 parts by weight of ethylene glycol, 6000 parts by weight of sesame oil, 3000 parts by weight of wide pellet.
Since plaster of the invention is substantially better than drug effect at low temperature in the drug effect being higher than under human body temperature, but this hair
The persistent fever time of bright plaster is about 0.5h, and due to the viscosity of plaster height, penetrating power is limited, and adds in plaster
Entering chitin fiber can reduce the compactness of plaster, to improve the diffusion velocity and seepage velocity of drug on skin, mention
The drug effect of high drug.Under optimum condition, in the preparation process of the ointment, chitin fiber is additionally added in ointment.
By being modified to chitin fiber, the compatibility of chitosan and plaster and the fiber of chitosan can be improved
Flexibility.Under optimum condition, the present invention is also modified the chitin fiber, the method for the modification are as follows: by the shell that alkalizes
Glycan fiber and imidazolyl heterocycle bi-quaternary ammonium salt are stirred to react 2~5h in isopropanol at 50~75 DEG C, then it is warming up to 80~
4~6h is kept the temperature at 100 DEG C, is then eluted product acetone 3 times, 60 DEG C are dried under reduced pressure 10h, obtain modification of chitosan；It is described
The weight ratio of chitosan and the quaternary ammonium salt is 1:0.11.
It is described alkalization chitosan the preparation method comprises the following steps: by chitosan mass fraction be 2% acetum in stir 1h,
The weight ratio for the acetum that the chitosan and the mass fraction are 2% is 1:20, and mass fraction, which is then slowly added dropwise, is
10% sodium hydroxide solution adjusts pH to 9, continues to stir 2h, filtering, the chitosan to be alkalized.
The imidazolyl heterocycle bi-quaternary ammonium salt the preparation method comprises the following steps: to reactor be added epoxychloropropane, be warming up to 75~85
DEG C, long-chain alkyl tertiary amine is slowly added dropwise and stirs 0.5h, is then cooled to 55 DEG C, and acetonitrile is added, is then added three times 1- hydroxyl
Ethyl-2-Methyl -5- nitroimidazole, insulation reaction 8h are cooled to room temperature, are concentrated under reduced pressure, obtain quaternary ammonium salt；The epoxy chloropropionate
The molar ratio of alkane and the long-chain alkyl tertiary amine, the metronidazole is 1:
0.64:0.7；The weight ratio of the epoxychloropropane and the acetonitrile is 1:6；The long-chain alkyl tertiary amine is selected from two
In methyl n-octyl amine, Dodecyl Dimethyl Amine, dodecyldimethylamine base tertiary amine and hexadecyldimethyl benzyl ammonium tertiary amine at least
It is a kind of.
The present invention also provides it is a kind of treat rheumatism bone disease, traumatic injury plaster preparation method, comprising the following steps:
(1) by pangolin, olibanum, safflower and borneol and grinding at powder, 120 meshes are then crossed；
By rhizoma typhonii, lopseed, prepared fleece flower root, ginseng, the rhizome of davallia, glutinous rehmannia, radix cyathulae, Rhizoma Et Radix Notopterygii, Rhizoma Gastrodiae, Rhizoma Chuanxiong, the black tip
It is smashed to pieces after snake, ramulus mori, rhizoma corydalis, Radix Angelicae Sinensis, pangolin powder, Radix Notoginseng cutting, then in the mixed solution of sesame oil and ethylene glycol
It is uniformly mixed, then continues to 3~8h of grinding, stand 5~10 days, and sealing tanning 5~7 days at 80~120 DEG C, remove the dregs of a decoction
After obtain medicine oil；
(2) wide red receipts cream is added in medicine oil, then adds olibanum, safflower, borneol and peppermint, obtains after mixing evenly
Ointment is poured into releasing fire-toxin 5~7 days in clear water, it is primary to change water daily by ointment.
In order to improve the service life and drug effect of the plaster, it is further preferred that further including optional in the auxiliary material
At least one of the preservative selected, antioxidant, moisturizer, sorbefacient.
Under optimum condition, the preservative is selected from benzoic acid and salt, potassium sorbate, dehydroactic acid sodium, P-hydroxybenzoic acid
Propyl ester, calcium propionate, sodium Diacetate, sodium lactate, streptococcus lactis, natamycin, hydrogen peroxide, sulfur dioxide, sulphite and
At least one of nitrite etc..
Under optimum condition, the antioxidant is selected from butylated hydroxy anisole, dibutyl hydroxy toluene, gallic acid third
At least one of ester, tert-butylhydroquinone, tocopherol and ascorbic acid.
Under optimum condition, the moisturizer is at least one of glycerol, propylene glycol, sorbierite.
Preferably, the sorbefacient is Laurocapram, EDTA, salicylic acid, amino acid 1-ethanamine derivatives, acetyl vinegar
At least one of acid esters, β-dicarboxylic ester, aromatic series acid compound, aliphatic acid.
Ointment of the invention it is applied widely, can be used for: 1, being suitable for patient with cervical Spondylopathy: spondylotic radiculopathy: back is heavy,
Shoulder pain, armache, hand fiber crops, muscle of upper extremity atrophy etc.；Vertebral artery type: headache, dizziness, nausea, dream be more, amnesia, palpitation, it is vexed,
Tinnitus eye is swollen etc.；
2, it is suitable for sciatica caused by protrusion of lumber intervertebral disc, osteoproliferation, strain, has a pain in the leg, leg fiber crops, leg is cool, lives
The crowd of the symptom such as dynamic limited, lower limb muscles atrophy；
3, suitable for being come to a point by articulatio genus hyperosteogeny, inconvenience of walking, hydrops articuli, knuckle, gap turn narrow, surrounding bone
Thorn, inconvenience of walking, the crowd of the symptoms such as joint stuffiness；
4, it is suitable for scapulohumeral periarthritis patient, it is unfavorable that upper limb is praised, and activity is impaired, the diseases such as shoulder joint local pain, swelling；
5, it is suitable for pain, dysarthrasis caused by rheumatism, rheumatoid osteopathia etc.
6, it is suitable for diabetes, disease of digestive system, the chronic diseases such as prostatitis；
7, sub-health population.
Through the above technical solutions, the present invention has following technical effect that
The present invention uses a variety of Chinese herbal medicine synergy, and comprehensive measure makes the effective ingredient of drug permeate lesion rapidly, changes
Kind diseased region blood circulation, reduces vascular resistence, eliminates tissue inflammatory oedema, alleviates muscular tone and spasm, restores rapidly
Neck, shoulder, waist, kneed active action, plaster have the function of eliminate wind and clear damp, cold dissipating network vessel quickening medicinal, activating microcirculation and removing stasis medicinal, dispersing swelling and dissipating binds,
Raw lesion at sufferer can be evicted from vitro, to rheumatism, rheumatoid, protrusion of lumber intervertebral disc, cervical spondylosis, gonitis, bone
Matter hyperplasia has good therapeutic effect, and the phenomenon that have no toxic side effect to skin, avoid the occurrence of pruitus, fester, both mentions
High drug effect, and comforts of use are improved, and quick, short treating period, cure rate are high, expense is small.
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to
Limit the present invention.
In following embodiment, the modified chitosan fiber the preparation method comprises the following steps:
(1) 0.1mol epoxychloropropane is added in reactor, is warming up to 75 DEG C, 0.064mol 16 is then slowly added dropwise
Alkyl dimethyl tertiary amide after being added dropwise, stirs 0.5h, is cooled to 55 DEG C, 0.6mol acetonitrile is added, is then added three times
0.7mol metronidazole is cooled to room temperature after insulation reaction 8h, is concentrated under reduced pressure to give quaternary ammonium salt；
(2) 100g chitin fiber is stirred into 1h in the acetum that 2000g mass fraction is 2%, then slowly dripped
Adding mass fraction is 10% sodium hydroxide solution, and regulation system pH is 9, continues to obtain alkalization chitin fiber after stirring 2h；
(3) it by 50g alkalization chitin fiber and 5.5g imidazolyl heterocycle bi-quaternary ammonium salt in isopropanol, is stirred at 60 DEG C anti-
3h is answered, is then warming up at 90 DEG C and keeps the temperature 5h, is then eluted product acetone 3 times, 60 DEG C are dried under reduced pressure 10h, are modified
Chitin fiber.
Embodiment 1
A kind of plaster for treating rheumatism bone disease, traumatic injury, the plaster are made of raw material from the following weight: rhizoma typhonii
12 parts by weight, 12 parts by weight of lopseed, 18 parts by weight of prepared fleece flower root, 15 parts by weight of pangolin, 15 parts by weight of safflower, 20 weight of ginseng
Measure part, 25 parts by weight of the rhizome of davallia, 30 parts by weight of glutinous rehmannia, 30 parts by weight of olibanum, 36 parts by weight of radix cyathulae, 36 parts by weight of Rhizoma Et Radix Notopterygii, day
Numb 36 parts by weight, 25 parts by weight of Rhizoma Chuanxiong, 25 parts by weight of zaocys dhumnade, 30 parts by weight of ramulus mori, 25 parts by weight of rhizoma corydalis, 36 weight of Radix Angelicae Sinensis
Part, 45 parts by weight of peppermint, 36 parts by weight of borneol, 60 parts by weight of Radix Notoginseng, 150 parts by weight of ethylene glycol, 6000 parts by weight of sesame oil, extensively
Red 3000 parts by weight.
It is described treatment rheumatism bone disease, traumatic injury plaster the preparation method comprises the following steps:
(1) by pangolin, olibanum, safflower and borneol and grinding at powder, 120 meshes are then crossed；
By rhizoma typhonii, lopseed, prepared fleece flower root, ginseng, the rhizome of davallia, glutinous rehmannia, radix cyathulae, Rhizoma Et Radix Notopterygii, Rhizoma Gastrodiae, Rhizoma Chuanxiong, the black tip
It is smashed to pieces after snake, ramulus mori, rhizoma corydalis, Radix Angelicae Sinensis, pangolin powder, Radix Notoginseng cutting, then in the mixed solution of sesame oil and ethylene glycol
It is uniformly mixed, then continues to grinding 5h, stand 8 days, and sealing tanning 5 days at 100 DEG C, obtain medicine oil after removing the dregs of a decoction；
(2) wide red receipts cream is added in medicine oil, then adds olibanum, safflower, borneol, peppermint, modified chitosan fiber,
Ointment is obtained after mixing evenly, and ointment is poured into releasing fire-toxin 5 days in clear water, it is primary to change water daily.
Embodiment 2
A kind of plaster for treating rheumatism bone disease, traumatic injury, the plaster are made of raw material from the following weight: rhizoma typhonii
15 parts by weight, 15 parts by weight of lopseed, 12 parts by weight of prepared fleece flower root, 15 parts by weight of pangolin, 18 parts by weight of safflower, 25 weight of ginseng
Measure part, 30 parts by weight of the rhizome of davallia, 30 parts by weight of glutinous rehmannia, 25 parts by weight of olibanum, 25 parts by weight of radix cyathulae, 25 parts by weight of Rhizoma Et Radix Notopterygii, day
Numb 25 parts by weight, 30 parts by weight of Rhizoma Chuanxiong, 30 parts by weight of zaocys dhumnade, 25 parts by weight of ramulus mori, 25 parts by weight of rhizoma corydalis, 25 weight of Radix Angelicae Sinensis
Part, 40 parts by weight of peppermint, 40 parts by weight of borneol, 60 parts by weight of Radix Notoginseng, 200 parts by weight of ethylene glycol, 5000 parts by weight of sesame oil, extensively
Red 2000 parts by weight.
It is described treatment rheumatism bone disease, traumatic injury plaster the preparation method comprises the following steps:
(1) by pangolin, olibanum, safflower and borneol and grinding at powder, 120 meshes are then crossed；
By rhizoma typhonii, lopseed, prepared fleece flower root, ginseng, the rhizome of davallia, glutinous rehmannia, radix cyathulae, Rhizoma Et Radix Notopterygii, Rhizoma Gastrodiae, Rhizoma Chuanxiong, the black tip
It is smashed to pieces after snake, ramulus mori, rhizoma corydalis, Radix Angelicae Sinensis, pangolin powder, Radix Notoginseng cutting, then in the mixed solution of sesame oil and ethylene glycol
It is uniformly mixed, then continues to grinding 5h, stand 8 days, and sealing tanning 5 days at 100 DEG C, obtain medicine oil after removing the dregs of a decoction；
(2) wide red receipts cream is added in medicine oil, then adds olibanum, safflower, borneol, peppermint, modified chitosan fiber,
Ointment is obtained after mixing evenly, and ointment is poured into releasing fire-toxin 5 days in clear water, it is primary to change water daily.
Embodiment 3
According to the method for embodiment 1, unlike, modified chitosan fiber is not contained.
The application method of plaster in Examples 1 to 3 are as follows:
The suitable plaster of size thickness is gone out according to affected part area sharing first, then plaster is placed on marble slab and is dropped
Temperature is cooled to the temperature of plaster rapidly close to skin temperature, then clears up the skin of patient affected part, and plaster is fast
Speed is affixed on thereon, after half an hour, etc. temperature drop to and be again close to slowly remove when skin temperature, and wipe body surface rapidly and extracted
The liquid come, finally embrocates liquid medicine again, is allowed to adequately be absorbed.
The mechanism of action of drug of the present invention are as follows:
By the lasting temperature of plaster, the pore of body surface and telangiectasis are opened, are the deep building channel of drug,
It is also simultaneously toxins in body, laying road is discharged in cold air.The entrance of taking advantage of a situation of drug, assembles in body, reaches most in the short time
Big blood concentration plays optimal pharmacological action, and under the synergistic effect of the drug contained, the perverse trend of body is forced body out
Outside, and with the decline of lotion temperature, pore is closed, and capillary contracture, toxin has just been retained in vitro.
" clinical test "
1, the standard of case is selected
It is diagnosed as rheumatism, rheumatoid arthritis patients according to card is faced, this medicine can be used.
Arthralgia, morning stiffness, arthroncus and tenderness, joint deformity and dysfunction, heumatism, limb rigidity, waist sacrum pain
Pain etc., it is rheumatism, rheumatoid arthritis patients that the patient with above-mentioned general symptom is diagnosable.
2, specific case selection: this group 515, the age 35~60 years old, average age 48.6 years old.
3, treatment method
The plaster of the treatment rheumatism bone disease of Examples 1 to 3, traumatic injury is sticked and affected part, daily dressing 1 time, one treats
Journey 7 days.
4, curative effect determinate standard
(1), cure: arthralgia, arthroncus disappear, and moving obstacle, joint deformity part are clearly better；
(2), effectively: arthralgia, arthroncus mitigate, and moving obstacle, joint deformity part gradually improve；
(3), invalid: arthralgia, arthroncus, moving obstacle, joint deformity are without any improvement.
5, treatment results
Curative effect is counted according to clinical sign and x-ray film making result.
| Treatment number | Healing number | Efficiently individual quantity | Invalid number | Treatment cycle | Total effective rate/% | |
| Embodiment 1 | 368 | 308 | 46 | 14 | 2~3 courses for the treatment of | 96.2 |
| Embodiment 2 | 99 | 83 | 8 | 8 | 2~3 courses for the treatment of | 91.9 |
| Embodiment 3 | 48 | 32 | 13 | 3 | 3~5 courses for the treatment of | 93.7 |
Foregoing description is only the description to section Example of the present invention, not to any restriction of the scope of the invention, current row
The those of ordinary skill of industry can according to the present invention make above-described embodiment and improve or modify, but belong to present invention protection model
It encloses.
Claims (4)
1. a kind of plaster for treating rheumatism bone disease, traumatic injury, which is characterized in that the plaster by following parts by weight raw material system
At: 10~20 parts by weight of rhizoma typhonii, 10~20 parts by weight of lopseed, 10~20 parts by weight of prepared fleece flower root, 10~20 weight of pangolin
Measure part, 10~20 parts by weight of safflower, 15~30 parts by weight of ginseng, 20~40 parts by weight of the rhizome of davallia, 20~40 parts by weight of glutinous rehmannia, cream
Fragrant 20~40 parts by weight, 15~50 parts by weight of radix cyathulae, 15~50 parts by weight of Rhizoma Et Radix Notopterygii, 15~50 parts by weight of Rhizoma Gastrodiae, Rhizoma Chuanxiong 15~
50 parts by weight, 15~50 parts by weight of zaocys dhumnade, 15~50 parts by weight of ramulus mori, 15~50 parts by weight of rhizoma corydalis, 15~50 weight of Radix Angelicae Sinensis
Amount part, 15~50 parts by weight of peppermint, 15~50 parts by weight of borneol, 50~70 parts by weight of Radix Notoginseng, 100~300 parts by weight of ethylene glycol,
3000~6000 parts by weight of sesame oil, 1500~3000 parts by weight of wide pellet.
2. it is according to claim 1 treatment rheumatism bone disease, traumatic injury plaster, which is characterized in that the plaster by with
The raw material of lower parts by weight is made: 15 parts by weight of rhizoma typhonii, 15 parts by weight of lopseed, 12 parts by weight of prepared fleece flower root, 15 weight of pangolin
Measure part, 18 parts by weight of safflower, 25 parts by weight of ginseng, 30 parts by weight of the rhizome of davallia, 30 parts by weight of glutinous rehmannia, 25 parts by weight of olibanum, river ox
25 parts by weight of knee, 25 parts by weight of Rhizoma Et Radix Notopterygii, 25 parts by weight of Rhizoma Gastrodiae, 30 parts by weight of Rhizoma Chuanxiong, 30 parts by weight of zaocys dhumnade, 25 weight of ramulus mori
Part, 25 parts by weight of rhizoma corydalis, 25 parts by weight of Radix Angelicae Sinensis, 40 parts by weight of peppermint, 40 parts by weight of borneol, 60 parts by weight of Radix Notoginseng, ethylene glycol
200 parts by weight, 5000 parts by weight of sesame oil, 2000 parts by weight of wide pellet.
3. it is according to claim 1 treatment rheumatism bone disease, traumatic injury plaster, which is characterized in that the plaster by with
The raw material of lower parts by weight is made: 12 parts by weight of rhizoma typhonii, 12 parts by weight of lopseed, 18 parts by weight of prepared fleece flower root, 15 weight of pangolin
Measure part, 15 parts by weight of safflower, 20 parts by weight of ginseng, 25 parts by weight of the rhizome of davallia, 30 parts by weight of glutinous rehmannia, 30 parts by weight of olibanum, river ox
36 parts by weight of knee, 36 parts by weight of Rhizoma Et Radix Notopterygii, 36 parts by weight of Rhizoma Gastrodiae, 25 parts by weight of Rhizoma Chuanxiong, 25 parts by weight of zaocys dhumnade, 30 weight of ramulus mori
Part, 25 parts by weight of rhizoma corydalis, 36 parts by weight of Radix Angelicae Sinensis, 45 parts by weight of peppermint, 36 parts by weight of borneol, 60 parts by weight of Radix Notoginseng, ethylene glycol
150 parts by weight, 6000 parts by weight of sesame oil, 3000 parts by weight of wide pellet.
4. the preparation method of the plaster for the treatment of rheumatism bone disease according to any one of claims 1 to 3, traumatic injury,
It is characterized in that, comprising the following steps:
(1) by pangolin, olibanum, safflower and borneol and grinding at powder, 120 meshes are then crossed；
By rhizoma typhonii, lopseed, prepared fleece flower root, ginseng, the rhizome of davallia, glutinous rehmannia, radix cyathulae, Rhizoma Et Radix Notopterygii, Rhizoma Gastrodiae, Rhizoma Chuanxiong, zaocys dhumnade, mulberry
It is smashed to pieces after branch, rhizoma corydalis, Radix Angelicae Sinensis, pangolin powder, Radix Notoginseng cutting, it is then equal with mixing in the mixed solution of sesame oil and ethylene glycol
It is even, 3~8h of grinding is then continued to, stands 5~10 days, and sealing tanning 5~7 days at 80~120 DEG C, is obtained after removing the dregs of a decoction
Medicine oil；
(2) wide red receipts cream is added in medicine oil, then adds olibanum, safflower, borneol and peppermint, obtains medicine after mixing evenly
Ointment is poured into releasing fire-toxin 5~7 days in clear water, it is primary to change water daily by cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811151016.7A CN108969666A (en) | 2018-09-29 | 2018-09-29 | It is a kind of to treat rheumatism bone disease, plaster of traumatic injury and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811151016.7A CN108969666A (en) | 2018-09-29 | 2018-09-29 | It is a kind of to treat rheumatism bone disease, plaster of traumatic injury and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108969666A true CN108969666A (en) | 2018-12-11 |
Family
ID=64543193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811151016.7A Pending CN108969666A (en) | 2018-09-29 | 2018-09-29 | It is a kind of to treat rheumatism bone disease, plaster of traumatic injury and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108969666A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109985222A (en) * | 2019-03-11 | 2019-07-09 | 徐良丰 | A kind of yin-yang moxibustion side and preparation method thereof |
| CN111110798A (en) * | 2019-08-09 | 2020-05-08 | 刘运章 | Traditional Chinese medicine spray for treating neck, shoulder, waist and leg pain, joint pain and hyperosteogeny |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1237427A (en) * | 1998-06-02 | 1999-12-08 | 张起来 | Adhesive plaster for curing prolapse of lumbar intervertebral disk |
| CN104524246A (en) * | 2015-01-22 | 2015-04-22 | 王雷 | Plaster for treating osteoarthropathy |
| CN104940868A (en) * | 2015-06-10 | 2015-09-30 | 李继敏 | Traditional Chinese medicine formula for treating cervical spondylosis, and cervical vertebra paste |
| CN105311138A (en) * | 2014-07-11 | 2016-02-10 | 焦振义 | Traditional Chinese medicine bone-strengthening powder for treating rheumatoid bone diseases |
-
2018
- 2018-09-29 CN CN201811151016.7A patent/CN108969666A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1237427A (en) * | 1998-06-02 | 1999-12-08 | 张起来 | Adhesive plaster for curing prolapse of lumbar intervertebral disk |
| CN105311138A (en) * | 2014-07-11 | 2016-02-10 | 焦振义 | Traditional Chinese medicine bone-strengthening powder for treating rheumatoid bone diseases |
| CN104524246A (en) * | 2015-01-22 | 2015-04-22 | 王雷 | Plaster for treating osteoarthropathy |
| CN104940868A (en) * | 2015-06-10 | 2015-09-30 | 李继敏 | Traditional Chinese medicine formula for treating cervical spondylosis, and cervical vertebra paste |
Non-Patent Citations (2)
| Title |
|---|
| 杨振泳: "《风湿骨病中医特色疗法杨氏堂技法》", 31 January 2011, 人民军医出版社 * |
| 杨明: "《中药药剂学》", 31 July 2016, 中国中医药出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109985222A (en) * | 2019-03-11 | 2019-07-09 | 徐良丰 | A kind of yin-yang moxibustion side and preparation method thereof |
| CN111110798A (en) * | 2019-08-09 | 2020-05-08 | 刘运章 | Traditional Chinese medicine spray for treating neck, shoulder, waist and leg pain, joint pain and hyperosteogeny |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102293874B (en) | Multifunctional medicinal pillow and preparation method thereof | |
| CN108685769A (en) | A kind of herbal mixture black hair anticreep shampoo and preparation method thereof | |
| CN108969666A (en) | It is a kind of to treat rheumatism bone disease, plaster of traumatic injury and preparation method thereof | |
| CN101342296A (en) | Medicament composition for preventing and controlling acne | |
| CN113509426A (en) | Plant extract compound capable of repairing striae gravidarum and striae adiposity and preparation method and application thereof | |
| CN105125467A (en) | Emulsion removing red blood and preparing method of emulsion | |
| CN105030620A (en) | Moisturizing and acne removing facial cleanser and preparing method thereof | |
| CN105147773B (en) | Traditional Chinese medicine composition with acne inhibition effect and preparation method and application thereof | |
| CN115813841B (en) | Anti-dandruff itching-relieving composition, preparation method and application thereof, shampoo and preparation method | |
| CN108078868B (en) | Antiallergic composition for skin care products | |
| CN105497537A (en) | Medicine composition with skin whitening and tendering functions and preparing method thereof | |
| CN109010520A (en) | A kind of ointment and preparation method thereof for treating dark sore | |
| CN104857461A (en) | Foot frostbite treatment foot bath foot soaking traditional Chinese medicine | |
| CN102138989B (en) | Chinese medicinal ointment for treating scalding, and preparation method and application thereof | |
| CN108514601A (en) | A kind of health care anti acne of traditional Chinese medicine and preparation method thereof | |
| KR20160036834A (en) | Skin external application composition comprising complex fermented extract of crude drug ingredients | |
| KR100644086B1 (en) | Method of manufacturing herbal baths without skin irritation | |
| CN110151657B (en) | Acne removing gel containing sedum sarmentosum extract and preparation method thereof | |
| CN113230374A (en) | External formula for treating cold in uterus and preparation method and application thereof | |
| CN112870140A (en) | Anti-allergy itching-relieving composition, skin-care gel, and preparation method and application thereof | |
| CN101518579B (en) | Pressure stabilizing deoppilant and preparation process | |
| CN101559175B (en) | Compound decoction of divaricate saposhnikovia root and eucommia bark for treating headache | |
| CN101317909A (en) | Externally used drug for treating difficult and complicated pain like tumour and preparation method thereof | |
| KR101201921B1 (en) | Slimming cosmetic compositions containing fagopyrum tataricym sprout extracts and preparing method thereof | |
| CN110051761A (en) | Topical agent of acne-removing inflammation-diminishing and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181211 |